A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas

Clinical trial NCT00711191 · COMPLETED

Trial details

NCT number: NCT00711191
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Neoplasm

Start date: 2008-06-01
Primary completion: 2011-01-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.